Cargando…

NKP30-B7-H6 Interaction Aggravates Hepatocyte Damage through Up-Regulation of Interleukin-32 Expression in Hepatitis B Virus-Related Acute-On-Chronic Liver Failure

BACKGROUND AND AIMS: Previous work conducted by our group has shown that the accumulation of hepatic natural killer (NK) cells and the up-regulation of natural cytotoxicity receptors (NKP30 and NKP46) on NK cells from patients with hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Yong, Bao, Junjie, Pan, Xingfei, Lu, Ying, Liao, Sihong, Wang, Xicheng, Wang, Guoying, Lin, Dongjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524618/ https://www.ncbi.nlm.nih.gov/pubmed/26241657 http://dx.doi.org/10.1371/journal.pone.0134568

Ejemplares similares

Expression and function of NKp46 W32R: the human homologous protein of mouse NKp46 W32R (Noé)
por: Glasner, Ariella, et al.
Publicado: (2017)

Expression Analysis of the Ligands for the Natural Killer Cell Receptors NKp30 and NKp44
por: Byrd, Andreina, et al.
Publicado: (2007)

Modulation of NKp30- and NKp46-Mediated Natural Killer Cell Responses by Poxviral Hemagglutinin
por: Jarahian, Mostafa, et al.
Publicado: (2011)

NKp44 and NKp30 splice variant profiles in decidua and tumor tissues: a comparative viewpoint
por: Shemesh, Avishai, et al.
Publicado: (2016)

Influenza A Virus Hemagglutinin and Other Pathogen Glycoprotein Interactions with NK Cell Natural Cytotoxicity Receptors NKp46, NKp44, and NKp30
por: Luczo, Jasmina M., et al.
Publicado: (2021)

Differential Expression of LLT1, SLAM Receptors CS1 and 2B4 and NCR Receptors NKp46 and NKp30 in Pediatric Acute Lymphoblastic Leukemia (ALL)
por: Powers, Sheila B., et al.
Publicado: (2023)

A NOVEL B7H3/NKP30 BISPECIFIC NK CELL ENGAGER FOR CANCER IMMUNOTHERAPY
por: Jiang, Xiaoling, et al.
Publicado: (2023)

NKp30(+) NK cells are associated with HBV control during pegylated-interferon-alpha-2b therapy of chronic hepatitis B
por: Shen, Xiaokun, et al.
Publicado: (2016)

Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer
por: Han, Bin, et al.
Publicado: (2018)

Altered NKp46 Recognition and Elimination of Influenza B Viruses
por: Duev-Cohen, Alexandra, et al.
Publicado: (2020)

Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6
por: Li, Yili, et al.
Publicado: (2011)

Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions
por: Garcia-Iglesias, Trinidad, et al.
Publicado: (2009)

Direct Recognition of Fusobacterium nucleatum by the NK Cell Natural Cytotoxicity Receptor NKp46 Aggravates Periodontal Disease
por: Chaushu, Stella, et al.
Publicado: (2012)

The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
por: Brandt, Cameron S., et al.
Publicado: (2009)

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis
por: Trabanelli, Sara, et al.
Publicado: (2017)

HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicity
por: Peipp, Matthias, et al.
Publicado: (2015)

Functional Differences between Human NKp44(−) and NKp44(+) RORC(+) Innate Lymphoid Cells
por: Hoorweg, Kerim, et al.
Publicado: (2012)

Frequency and role of NKp46 and NKG2A in hepatitis B virus infection
por: Yoshioka, Teppei, et al.
Publicado: (2017)

Natural Killer Cell Activation Receptor NKp30 Oligomerization Depends on Its N-Glycosylation
por: Skořepa, Ondřej, et al.
Publicado: (2020)

NKp44 and Natural Cytotoxicity Receptors as Damage-Associated Molecular Pattern Recognition Receptors
por: Horton, Nathan C., et al.
Publicado: (2015)

NKp46 regulates allergic responses
por: Ghadially, Hormas, et al.
Publicado: (2013)

Secreted Ligands of the NK Cell Receptor NKp30: B7-H6 Is in Contrast to BAG6 Only Marginally Released via Extracellular Vesicles
por: Ponath, Viviane, et al.
Publicado: (2021)

Activatory Receptor NKp30 Predicts NK Cell Activation During Controlled Human Malaria Infection
por: Walk, Jona, et al.
Publicado: (2019)

Innate-like NKp30(+)CD8(+) T cells armed with TCR/CAR target tumor heterogeneity
por: Correia, Margareta P., et al.
Publicado: (2021)

A novel mucosal RORγt(+)NKp46(+) cell subset is a source of interleukin-22
por: Tomasello, Elena, et al.
Publicado: (2009)

Interleukin-22 Secreted by NKp44+ Natural Killer Cells Promotes Proliferation of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis
por: Zhu, Junqing, et al.
Publicado: (2015)

Celiac Disease-Related Inflammation Is Marked by Reduction of Nkp44/Nkp46-Double Positive Natural Killer Cells
por: Marafini, Irene, et al.
Publicado: (2016)

NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans
por: Parodi, Monica, et al.
Publicado: (2019)

First Trimester Pregnancy Loss and the Expression of Alternatively Spliced NKp30 Isoforms in Maternal Blood and Placental Tissue
por: Shemesh, Avishai, et al.
Publicado: (2015)

Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1
por: Walwyn-Brown, Katherine, et al.
Publicado: (2018)

NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
por: Chretien, Anne-Sophie, et al.
Publicado: (2017)

Natural Killer Cells from the Subcutaneous Adipose Tissue Underexpress the NKp30 and NKp44 in Obese Persons and Are Less Active against Major Histocompatibility Complex Class I Non-Expressing Neoplastic Cells
por: Shoae-Hassani, Alireza, et al.
Publicado: (2017)

The Effects of Conditioned Medium Derived from Mesenchymal Stem Cells Cocultured with Hepatocytes on Damaged Hepatocytes and Acute Liver Failure in Rats
por: Chen, Li, et al.
Publicado: (2018)

Analysis of NKp30/NCR3 isoforms in untreated HIV-1-infected patients from the ANRS SEROCO cohort
por: Prada, Nicole, et al.
Publicado: (2013)

Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
por: Chretien, Anne-Sophie, et al.
Publicado: (2019)

NKp30 Receptor Upregulation in Salivary Glands of Sjögren’s Syndrome Characterizes Ectopic Lymphoid Structures and Is Restricted by Rituximab Treatment
por: Pontarini, Elena, et al.
Publicado: (2021)

Dependence of innate lymphoid cell 1 development on NKp46
por: Wang, Yufeng, et al.
Publicado: (2018)

Bovine neonate natural killer cells are fully functional and highly responsive to interleukin-15 and to NKp46 receptor stimulation
por: Elhmouzi-Younes, Jamila, et al.
Publicado: (2009)

B7-H6, an immunoligand for the natural killer cell activating receptor NKp30, reveals inhibitory effects on cell proliferation and migration, but not apoptosis, in cervical cancer derived-cell lines
por: Banu, Nehla, et al.
Publicado: (2020)

Symphonies 21, 30-32
por: Haydn, Michael, 1737-1806
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_i79ea52ripqlf1e2kn7vfdq1d6